Pasar al contenido principal

DESARROLLO DE NUEVOS NANO-VEHICULOS PARA SUPERAR LA RESISTENCIA A FARMACOS DEL ADENOCARCINOMA PANCREATICO Y SU VALIDACION MEDIANTE MODELOS CELULARES 3D MIXTOS

PID2021-126346OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT RAMON LLULL, FUNDACIO PRIVADA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

CD47 peptide-albumin cloaked mesoporous silica nanoparticles for enhanced macrophage evasion and synergistic combination therapy

  • Pontón, Iris
  • Núñez Martínez-Quintanilla, Sandra
  • Díaz-Perlas, Cristina
  • Oller-Salvia, Benjamí
  • Semino, Carlos
  • Sánchez-García, David
Upon introduction into the bloodstream, nanoparticles are rapidly enveloped by plasma proteins, forming a protein corona (PC) that typically accelerates their clearance via opsonization and macrophage uptake. However, specific proteins, such as albumin, exhibit dysopsonin properties, reducing sequestration and prolonging systemic circulation. In this study, we have developed a nanocarrier (DOX/Ce6@MSN-EMal-BSA/SP1) based on mesoporous silica nanoparticles (MSNs) coated with a light-responsive PC that prevents macrophage recognition and enables the controlled release of doxorubicin (DOX). The PC comprises bovine serum albumin (BSA) anchored to the MSN surface through a novel singlet oxygen-sensitive linker, with further functionalization using a CD47-mimetic peptide (SP1) to enhance immune evasion. BSA coating resulted in a 1.9-fold reduction in uptake by macrophage cultures compared to uncoated MSNs. Incorporation of SP1 further diminished macrophage internalization by 3.5-fold, as quantified by in vitro assays. Red light irradiation (660 nm) triggers cleavage of the singlet oxygen-sensitive linker, leading to PC shedding and subsequent DOX release. In vitro cytotoxicity evaluations against pancreatic cancer cell lines demonstrated potent efficacy: the nanocarrier exhibited an IC50 of 0.99 μg mL−1 against MIA PaCa-2 cells and 1.74 μg mL−1 against PANC-1 cells. This high cytotoxicity is attributed to a synergistic effect (CI = 0.40 for MIA PaCa-2 and 0.17 for PANC-1) resulting from the photodynamic generation of singlet oxygen by chlorin e6 (Ce6) and the chemotherapeutic action of released DOX. These findings underscore the nanocarrier's potential for precision drug delivery in combination therapeutic modalities., info:eu-repo/semantics/acceptedVersion
DAU Arxiu Digital de la Universitat Ramon Llull
Publicación Artículo científico (JournalArticle)

An Orthogonally Clickable and Stimuli-Responsive Poly(β-amino ester) for the Co-delivery of Doxorubicin and BCL-2 siRNA

  • Martí del Rio, Andrea
  • Sánchez-García, David
A potent drug delivery system (DDS) based on poly(β-amino ester)s (pBAEs) to tackle multidrug resistance (MDR) in lung cancer by codelivering siRNA targeting antiapoptotic BCL-2 and doxorubicin (DOX) has been prepared. Engineered via strain-promoted azide–alkyne cycloaddition (SPAAC) to attach a tripeptide end-chain moiety and thiol–disulfide exchange to conjugate DOX, the system employs a hydrazone linker for dual pH- and redox-responsive release. This ensures precise tumor targeting with minimal leakage in the circulation. In multidrug-resistant lung cancer cells (GLC-4/ADR), it sharply downregulates BCL-2 expression, amplifying DOX’s therapeutic impact., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

An Orthogonally Clickable and Stimuli-Responsive Poly(β-amino ester) for the Co-delivery of Doxorubicin and BCL-2 siRNA

  • Martí del Rio, Andrea
  • Sánchez-García, David
A potent drug delivery system (DDS) based on poly(β-amino ester)s (pBAEs) to tackle multidrug resistance (MDR) in lung cancer by codelivering siRNA targeting antiapoptotic BCL-2 and doxorubicin (DOX) has been prepared. Engineered via strain-promoted azide–alkyne cycloaddition (SPAAC) to attach a tripeptide end-chain moiety and thiol–disulfide exchange to conjugate DOX, the system employs a hydrazone linker for dual pH- and redox-responsive release. This ensures precise tumor targeting with minimal leakage in the circulation. In multidrug-resistant lung cancer cells (GLC-4/ADR), it sharply downregulates BCL-2 expression, amplifying DOX’s therapeutic impact., info:eu-repo/semantics/publishedVersion
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

CD47 peptide-albumin cloaked mesoporous silica nanoparticles for enhanced macrophage evasion and synergistic combination therapy

  • Pontón, Iris
  • Núñez Martínez-Quintanilla, Sandra
  • Díaz-Perlas, Cristina
  • Oller-Salvia, Benjamí
  • Semino, Carlos
  • Sánchez-García, David
Upon introduction into the bloodstream, nanoparticles are rapidly enveloped by plasma proteins, forming a protein corona (PC) that typically accelerates their clearance via opsonization and macrophage uptake. However, specific proteins, such as albumin, exhibit dysopsonin properties, reducing sequestration and prolonging systemic circulation. In this study, we have developed a nanocarrier (DOX/Ce6@MSN-EMal-BSA/SP1) based on mesoporous silica nanoparticles (MSNs) coated with a light-responsive PC that prevents macrophage recognition and enables the controlled release of doxorubicin (DOX). The PC comprises bovine serum albumin (BSA) anchored to the MSN surface through a novel singlet oxygen-sensitive linker, with further functionalization using a CD47-mimetic peptide (SP1) to enhance immune evasion. BSA coating resulted in a 1.9-fold reduction in uptake by macrophage cultures compared to uncoated MSNs. Incorporation of SP1 further diminished macrophage internalization by 3.5-fold, as quantified by in vitro assays. Red light irradiation (660 nm) triggers cleavage of the singlet oxygen-sensitive linker, leading to PC shedding and subsequent DOX release. In vitro cytotoxicity evaluations against pancreatic cancer cell lines demonstrated potent efficacy: the nanocarrier exhibited an IC50 of 0.99 μg mL−1 against MIA PaCa-2 cells and 1.74 μg mL−1 against PANC-1 cells. This high cytotoxicity is attributed to a synergistic effect (CI = 0.40 for MIA PaCa-2 and 0.17 for PANC-1) resulting from the photodynamic generation of singlet oxygen by chlorin e6 (Ce6) and the chemotherapeutic action of released DOX. These findings underscore the nanocarrier's potential for precision drug delivery in combination therapeutic modalities., info:eu-repo/semantics/acceptedVersion